samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > flexible packaging protects against contamination
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Flexible Packaging Protects Against Contamination

This article gives an overview of the regulatory background on the prevention of contamination during the manufacturing and packing process of APIs, drugs or vaccines. Flexible packaging could be an ideal solution, providing suitable protection for this purpose at a relatively low cost.

Fulfilment of regulatory compliance according to European Pharmacopoeia (EP) or United States Pharmacopeia (USP) is often a primary concern, along with suitable documentation and traceability of all qualityrelated items. However, flexible packaging has to fulfil further requirements; the cleanliness of both high-purity bulk material and the production area have to be protected.

Pharmaceutical and medical products are increasingly closely linked to cleanliness. The gap between the requirements of hospital used materials and the needs of the pharmaceutical industry is growing continuously. The cleanliness required for pharmaceuticals, especially for sterile active...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Benjamin Kepp has worked for Bischof + Klein GmbH & Co KG since 2000. In his apprenticeship he had the chance to combine working for B+K with studying economics and commercial law. A further study has successfully been finished with a state-approved BA thereafter. Nowadays, he is engaged as part of the Product Management for CleanFlex® packaging materials.
spacer
Benjamin Kepp
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Biopharmaceuticals company attends sector conferences in the online format

A leading Contract Development and Manufacturing Organization (CDMO), 3P Biopharmaceuticals, specialized in process development and cGMP manufacturing of biologics, is attending the most relevant events of the sector, although in digital format, as a consequence of the cancellation of global events due to the pandemic. COVID19 has affected everyone and all sectors.
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement